Dudediligence.

Johnson & Johnson

JNJNYSE · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

2.41B

on 2026-07-17, from 2.41B on 2024-04-25 10-Q ↗

Newest

No limit

S-3ASR of 2026-02-11. An automatic shelf: the form sets no dollar limit. None sold under it to 2026-10-05. S-3ASR ↗

5 of its filings are not read yet.

Warrants

The 10-Q filed 2026-07-23 is not read yet.

Cash

$20.76B

Operating cash flow was positive over the four quarters to 2026-06-28, so no quarters are counted. 10-Q ↗

Raised: 6 of its filings are not read yet.